538 related articles for article (PubMed ID: 26511936)
21. Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation.
Dong Z; Chatterji A; Sandhu H; Choi DS; Chokshi H; Shah N
Int J Pharm; 2008 May; 355(1-2):141-9. PubMed ID: 18243605
[TBL] [Abstract][Full Text] [Related]
22. Holistic QbD approach for hot-melt extrusion process design space evaluation: Linking materials science, experimentation and process modeling.
Evans RC; Bochmann ES; Kyeremateng SO; Gryczke A; Wagner KG
Eur J Pharm Biopharm; 2019 Aug; 141():149-160. PubMed ID: 31132400
[TBL] [Abstract][Full Text] [Related]
23. Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
Hengsawas Surasarang S; Keen JM; Huang S; Zhang F; McGinity JW; Williams RO
Drug Dev Ind Pharm; 2017 May; 43(5):797-811. PubMed ID: 27616147
[TBL] [Abstract][Full Text] [Related]
24. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
25. Effect of carbamazepine on viscoelastic properties and hot melt extrudability of Soluplus ®.
Gupta SS; Parikh T; Meena AK; Mahajan N; Vitez I; Serajuddin ATM
Int J Pharm; 2015 Jan; 478(1):232-239. PubMed ID: 25448585
[TBL] [Abstract][Full Text] [Related]
26. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
[TBL] [Abstract][Full Text] [Related]
27. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.
Maniruzzaman M; Islam MT; Halsey S; Amin D; Douroumis D
AAPS PharmSciTech; 2016 Feb; 17(1):191-9. PubMed ID: 26689407
[TBL] [Abstract][Full Text] [Related]
28. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
[TBL] [Abstract][Full Text] [Related]
29. Rheological analysis of itraconazole-polymer mixtures to determine optimal melt extrusion temperature for development of amorphous solid dispersion.
Solanki N; Gupta SS; Serajuddin ATM
Eur J Pharm Sci; 2018 Jan; 111():482-491. PubMed ID: 29080855
[TBL] [Abstract][Full Text] [Related]
30. New investigation of distribution imaging and content uniformity of very low dose drugs using hot-melt extrusion method.
Park JB; Kang CY; Kang WS; Choi HG; Han HK; Lee BJ
Int J Pharm; 2013 Dec; 458(2):245-53. PubMed ID: 24157343
[TBL] [Abstract][Full Text] [Related]
31. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
Zhao M; Barker SA; Belton PS; McGregor C; Craig DQ
Eur J Pharm Biopharm; 2012 Nov; 82(3):572-9. PubMed ID: 22922419
[TBL] [Abstract][Full Text] [Related]
32. Interactions between drugs and polymers influencing hot melt extrusion.
Li Y; Pang H; Guo Z; Lin L; Dong Y; Li G; Lu M; Wu C
J Pharm Pharmacol; 2014 Feb; 66(2):148-66. PubMed ID: 24325738
[TBL] [Abstract][Full Text] [Related]
33. Novel Hot Melt Extruded Matrices of Hydroxypropyl Cellulose and Amorphous Felodipine-Plasticized Hydroxypropyl Methylcellulose as Controlled Release Systems.
Yi S; Wang J; Lu Y; Ma R; Gao Q; Liu S; Xiong S
AAPS PharmSciTech; 2019 Jun; 20(6):219. PubMed ID: 31201583
[TBL] [Abstract][Full Text] [Related]
34. Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.
Agrawal AM; Dudhedia MS; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):133-47. PubMed ID: 26729533
[TBL] [Abstract][Full Text] [Related]
35. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ
J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488
[TBL] [Abstract][Full Text] [Related]
36. Hot melt extruded Aprepitant-Soluplus solid dispersion: preformulation considerations, stability and in vitro study.
Penumetcha SS; Gutta LN; Dhanala H; Yamili S; Challa S; Rudraraju S; Rudraraju S; Rudraraju V
Drug Dev Ind Pharm; 2016 Oct; 42(10):1609-20. PubMed ID: 26925514
[TBL] [Abstract][Full Text] [Related]
37. In-process rheometry as a PAT tool for hot melt extrusion.
Kelly AL; Gough T; Isreb M; Dhumal R; Jones JW; Nicholson S; Dennis AB; Paradkar A
Drug Dev Ind Pharm; 2018 Apr; 44(4):670-676. PubMed ID: 29161918
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of extended release Kollidon SR mini-matrices prepared by hot-melt extrusion.
Ozgüney I; Shuwisitkul D; Bodmeier R
Eur J Pharm Biopharm; 2009 Sep; 73(1):140-5. PubMed ID: 19406237
[TBL] [Abstract][Full Text] [Related]
39. Study the influence of formulation process parameters on solubility and dissolution enhancement of efavirenz solid solutions prepared by hot-melt extrusion: a QbD methodology.
Pawar J; Suryawanshi D; Moravkar K; Aware R; Shetty V; Maniruzzaman M; Amin P
Drug Deliv Transl Res; 2018 Dec; 8(6):1644-1657. PubMed ID: 29426975
[TBL] [Abstract][Full Text] [Related]
40. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion.
Liu X; Lu M; Guo Z; Huang L; Feng X; Wu C
Pharm Res; 2012 Mar; 29(3):806-17. PubMed ID: 22009589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
